T2 Biosystems, Inc.

5.52 USD
-0.12 (-2.13%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

T2 Biosystems, Inc. stock is up 86.49% since 30 days ago. The next earnings date is Feb 15, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 9 May’s closed higher than April. 0% of analysts rate it a buy.

About T2 Biosystems, Inc.

T2 Biosystems, Inc. develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagnostic tests from patient samples.